For citations:
Gantsev Sh.Kh., Umezawa K. Importance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQ. Creative surgery and oncology. 2019;9(1):87-88. https://doi.org/10.24060/2076-3093-2019-9-1-87-88
Gantsev Sh.Kh., Umezawa K. Importance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQ. Creative surgery and oncology. 2019;9(1):87-88. https://doi.org/10.24060/2076-3093-2019-9-1-87-88